Meet the Doctor
Tracy Evans M.D.
Dr. Evans graduated with honors, Phi Beta Kappa from Vassar College in New York. She attended medical school at the University of Connecticut where she completed both her medical school training and earned a Master degree in Public Health. She conducted research for the National Institute of Heath for two years on skin cancer. Dr. Evans completed her residency in Dermatology at Emory University in Atlanta, Georgia. She was fellowship trained and certified by the American College of Mohs Micrographic Surgery and Accreditation Council of Graduate Medical Education at the University of Pittsburgh Medical Center. Dr. Evans founded her private practice in San Francisco, CA in 2008. Dr. Evans has authored several articles and book chapters on skin cancer and Mohs surgery. She has presented at multiple national and international meetings for her research on cost, quality of life, and skin cancer outcomes. Dr. Evans is a Fellow of the American Academy of Dermatology, and a member of the American Society of Dermatologic Surgery, the American Society for Laser Medicine and Surgery, the American College of Mohs Surgery, the California Society for Dermatology and Dermatologic Surgery and the American Medical Association.
Private Practice: Surgical, Medical and Cosmetic Dermatology
Fellowship trained Mohs Surgeon and Skin Cancer Specialist
Associate of American College of Mohs Surgery
Board Certified Dermatologist
August 11, 2008
ACMMSCO/ ACGME Mohs & Procedural Dermatology Fellowship
Fellowship Directors: John A Zitelli M.D and David G. Brodland M.D.
- Cutaneous Oncology: 2500 cases/year, fellow performs 1000 cases including: BCC, SCC, Merkel Cell, AFX, DFSP, extra mammary Pagets disease, sebaceous carcinoma, Lentigo Maligna, Melanoma with MART-1 immunoperoxidase stains for margin control
- Reconstruction & Cosmetics: flaps, full and split thickness skin grafts, cartilage grafting, ear reconstruction, scar revision, botox, lasers, sclerotherapy
Dermatology Chief Resident Emory University School of Medicine, Department of Dermatology
Chairman: S. Wright Caughman M.D.
Dermatology Resident Emory University School of Medicine, Department of Dermatology
Chairman: S. Wright Caughman M.D.
Dermatology Outcomes Research Fellowship
National Research Service Award, National Institute of Health, funded research fellow at Emory University Department of Dermatology and Emory Center for Outcomes Research
Mentor: Suephy C. Chen M.D., MS
Transitional Internship Emory University Department of Medicine
Chairman: Wayne Alexander, M.D., PhD
Current Active State Medical Licenses
California, Arizona, Pennsylvania, Georgia
University of Connecticut School of Medicine Doctor of Medicine
University of Connecticut School of Public Health Master of Public Health
Master in Public Health Thesis Evidence-guided approach to understanding the contribution of dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. (Bialy TL, Rothe MJ, Grant-Kels JM. Dietary factors in the prevention and treatment of
nonmelanoma skin cancer and melanoma. Dermatologic Surgery, 28:12, 2002, 1143-52.)
Vassar College Bachelor of Arts
Graduated with Honors, Phi Beta Kappa
Bramlette TB, Lawson DH, Washington CV, Veladar E, Johns B, Freedman S, Abromova L, Chen SC. 2b or not 2b? Significant differences exist in the decision making process between melanoma patients who accept or decline high-dose adjuvant interferon alfa-2b. Dermatologic Surgery and winner of 2006 ASDS Young Investigators Writing Competition, July 2006
Dermatologic Surgery 33 (1), 11–16.
Seidler AM, Bramlette TB, Washington CV, Setzo H, Whalen J, Chen SC. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: An analysis of cost effectiveness. Dermatologic Surgery. September 2009.
Bialy TL, Whalen J, Veledar E, Chartier T, Lafreniere D, Spiro J, Chen SC. Mohs surgery vs standard excision: A cost comparison analysis. Arch Dermatol. 2004; 140:736-742.
Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS. Poor prognosis of arthritis-associated pyoderma gangrenosum. Arch Dermatol. 2004; 140(7):861-864.
Bialy TL, Rothe MJ, Grant-Kels JM. Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. Dermatologic Surgery, 2002 Dec; 28(12):1143-52.
Rothe MJ, Bialy TL, Grant-Kels JM. Erythroderma. Dermatologic Clinics, Inpatient Dermatology. July 2000, 18; 405-415.
Bialy TL, Wei H. Epidermodysplasia verruciformis. In: Lebwohl M, Heymann W, Berth-Jones J, Coulson I, editors. Treatment of Skin Disease, Harcourt Health Sciences, 2002.
Rothe MJ, Bialy TL, Grant-Kels JM. Skin Cancer. In: Wu G. M.D. PhD. Screening for Common Malignancies: A Practical Guide, Humana Press, 2001.
, Lawson DH, Washington CV, Veladar E, Johns B, Freedman S, Abromova L, Chen SC. 2b or Not 2b? Significant differences exist in the decision making process between melanoma patients who accept or decline high-dose adjuvant interferon alfa-2b
- Oral Presentation at the American Society for Dermatologic Surgery Oct. 2006, Palm Desert, CA
Click here to view Dr. Evans full curriculum vitae.